In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
The U.S. Food and Drug Administration reports the number of Thoroughbreds who died after receiving a compounded drug from Wickliffe Pharmacy in Lexington, Ky. has grown to four, and six others have become ill.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
Scientists are warning horse owners and veterinarians to be cautious about using compounded (private pharmacy-mixed) gastric ulcer medications.
Most Popular Stories
- First Foal by Fast Anna Born in New York
- Untapped Takes First Steps Toward Filling Big Shoes
- End of Fair Grounds Quarantine Appears to be on Horizon
- Remains of Glacial Princess to be Moved to Old Friends
- Keeneland Announces Spring Meet Stakes Schedule
- Japan Gets a NY Filly as His First Foal
- The Big Beast Gets a Florida-Bred Colt as First Foal
- Spendthrift Juvenile Stallion Stakes to Add Filly Race
- Texas Chrome Named Texas Horse of the Year
- Finnegans Wake to Stand at Ballena Vista Farm